多发性硬化3D T2暗液序列深度学习加速重建与传统序列可互换性研究
本前瞻性研究纳入94例确诊或疑诊慢性炎性中枢神经系统疾病患者,于1.5T MRI同时采集传统3D T2暗液序列(5分01秒)与深度学习加速3D T2暗液序列(2分48秒)。三名独立阅片者及一名资深神经放射医师使用认证病灶检测软件评估新发白质病灶,以2024修订版McDonald标准为参考。结果显示两序列在新发白质病灶检出方面具有可互换性,等效性指数均在预设5%界值内。
要点
- DL加速3D T2暗液序列可检出与传统序列一致的新发白质病灶,采集时间缩短近50%。
- 幕下及脑室旁病灶总数一致性几乎完美,皮质/近皮质病灶一致性为良好。
- 主观图像质量评分部分阅片者认为传统序列更优,可酌情降低加速倍数以改善质量。
核心结论
- DL加速3D T2加权暗液序列在检出多发性硬化新发白质病灶方面与传统3D序列具有可互换性,同时采集时间缩短近50%。
- DL加速序列可支持更高效的多发性硬化常规监测MRI方案,为额外高级序列的纳入提供时间空间。
- 考虑到DL加速序列主观图像评分稍逊于传统序列,可适当降低加速因子以提升图像质量。
研究设计与样本
- 前瞻性研究,纳入94例确诊多发性硬化(n=77)或疑诊慢性炎性中枢神经系统疾病(n=17)患者。
- 所有受试者于1.5T MRI分别接受传统3D T2 SPACE暗液序列(5分01秒)与DL加速3D T2 SPACE暗液序列(2分48秒)扫描。
- 以2024修订版McDonald标准定义的新发白质病灶检出作为主要终点,预设可互换性等效界值为5%。
- 病灶由3名独立阅片者及1名资深神经放射医师使用认证的病灶检测软件在脑室旁、皮质/近皮质及幕下三个解剖区域进行评估。
- 73例患者有可比的既往检查且满足AI病灶检测软件技术要求,其中13例确认存在新发病灶。
关键影像表现/征象
- DL加速3D T2暗液序列与传统序列在脑室旁、皮质/近皮质及幕下三个解剖区域的新发白质病灶检出方面具有可比性。
- 幕下及脑室旁病灶总数一致性几乎完美,皮质/近皮质病灶总数一致性为良好。
- 主观分析显示2名阅片者认为传统3D T2序列图像质量显著更优,1名阅片者认为传统序列诊断信心显著更高。
诊断标准与关键数值
- 新发白质病灶检出等效性指数在所有阅片者及资深神经放射医师中均保持在预设5%等效界值以内。
- 新发白质病灶检出的方法间一致性总体Gwet's AC2值为0.85[0.74;0.96]至0.98[0.95;1.00]。
- 新发白质病灶阅片者间一致性总体Gwet's AC2值为0.85[0.76;0.94]。
- 幕下及脑室旁病灶总数一致性Gwet's AC2≥0.93[0.91;0.96],皮质/近皮质病灶总数一致性为0.71[0.65;0.77]。
临床应用与阅片要点
- DL加速3D T2暗液序列可用于多发性硬化患者常规监测新发白质病灶,尤其适用于随访对比场景。
- 使用认证或经验证的病灶检测软件有助于保证DL加速序列与传统序列之间的评估一致性。
- 对图像质量要求较高时,可考虑适度降低加速因子以在时间节省与图像质量间取得平衡。
局限性
- 主观图像质量评估中部分阅片者认为DL加速序列图像质量显著低于传统序列。
- 并非所有入组患者有可比的既往检查满足AI病灶检测软件的技术要求。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Deep-learning (DL)-accelerated MRI can significantly reduce acquisition times. Studies evaluating interchangeability with conventional 3D data sets, particularly for monitoring disease activity in multiple sclerosis (MS), are lacking. This study investigated interchangeability and comparability between conventional fluid-attenuated 3D-T2-SPACE dark-fluid (c-3D-T2) and accelerated DL-based fluid-attenuated 3D-T2-SPACE dark-fluid (DL-3D-T2) in detecting new white matter lesions lesions on brain MRIs.
MATERIALS AND METHODS: In this prospective study, 94 patients with confirmed MS (n=77) or suspected chronic inflammatory CNS disease (n=17), underwent clinically indicated brain MRI at 1.5T. Each participant underwent both c-3D-T2 (5:01 min) and DL-3D-T2 (2:48 min) imaging. Primary endpoint was interchangeability of both sequences for detecting new white matter lesions defined according to the 2024 revised McDonald criteria. Furthermore, comparability regarding total lesion count and image quality was evaluated. Lesions were assessed in 3 anatomic regions (periventricular, cortical/juxtacortical, and infratentorial) by 3 independent readers and 1 experienced neuroradiologist using an established, certified lesion-detection software. Equivalence margin for interchangeability was predefined at 5%. Gwet's AC1 and AC2 determined inter-reader reliability.
RESULTS: The study comprised of 70 women and 24 men, with a mean age of 44.9 years (range: 24 to 72 y). In 73 patients, a comparable prior examination was available and met the technical requirements for AI-based lesion-detection software. In 13 patients new lesions were confirmed. Interchangeability for the primary endpoint was demonstrated for all readers and the experienced neuroradiologist, using certified lesion-detection software. Individual equivalence indices remained within the 5% margin. Detection of new white matter lesions demonstrated almost perfect inter-method agreement with overall Gwet's AC2 values between 0.85 [0.74; 0.96] and 0.98 [0.95; 1.00], and excellent inter-reader reliability, with overall new lesions of 0.85 [0.76; 0.94]. Total number of infratentorial and periventricular lesions demonstrated almost perfect agreement [(≥0.93 (0.91; 0.96)] and good agreement for cortical/juxtacortical lesions [0.71 (0.65; 0.77)]. Subjective analysis revealed that 2 readers rated c-3D-T2 as significantly superior in image quality (P<0.001) and 1 reader rated c-3D-T2 as significantly superior in diagnostic confidence (P=0.003).
CONCLUSIONS: DL-accelerated 3D-T2-weighted imaging is interchangeable with conventional 3D imaging for detecting new white matter lesions, while reducing acquisition time by nearly 50%. This acceleration supports more efficient MRI protocols for routine MS surveillance, enabling inclusion of additional advanced sequences. However, as subjective image evaluation was slightly inferior in DL-accelerated data sets, and given the substantial time savings, it may be reasonable to slightly reduce the acceleration factor to enhance image quality.
引用
- Altmann, Mercado, Michael, et al. Accelerated Deep-Learning-Based Image Reconstruction for 3D T2 Dark-Fluid in Imaging of Multiple Sclerosis. Invest Radiol. 2026. PMID: 42400420. doi:10.1097/RLI.0000000000001300
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。